Galactosylation of IgG from rheumatoid arthritis (RA) patients – changes during therapy
Galactosylation of IgG from rheumatoid arthritis (RA) patients – changes during therapy
About this item
Full title
Author / Creator
Publisher
United States: Springer Nature B.V
Journal title
Language
English
Formats
Publication information
Publisher
United States: Springer Nature B.V
Subjects
More information
Scope and Contents
Contents
It is well documented that serum IgG from rheumatoid arthritis (RA) patients exhibits decreased galactosylation of its conservative N-glycans (Asn-297) in CH2 domains of the heavy chains; it has been shown that this agalactosylation is proportional to disease severity. In the present investigation we analyzed galactosylation of IgG derived from the...
Alternative Titles
Full title
Galactosylation of IgG from rheumatoid arthritis (RA) patients – changes during therapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_874178712
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_874178712
Other Identifiers
ISSN
0282-0080
E-ISSN
1573-4986
DOI
10.1007/s10719-006-5409-0
